Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection.

Zhu WG, Xua DF, Pu J, Zong CD, Li T, Tao GZ, Ji FZ, Zhou XL, Han JH, Wang CS, Yu CH, Yi JG, Su XL, Ding JX.

Radiother Oncol. 2012 Sep;104(3):361-6. doi: 10.1016/j.radonc.2012.08.024. Epub 2012 Sep 14.

PMID:
22985776
2.

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.

Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, Haller DG, Ajani JA, Gunderson LL, Jessup JM, Martenson JA.

N Engl J Med. 2001 Sep 6;345(10):725-30.

3.

Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial.

Lee J, Lim do H, Kim S, Park SH, Park JO, Park YS, Lim HY, Choi MG, Sohn TS, Noh JH, Bae JM, Ahn YC, Sohn I, Jung SH, Park CK, Kim KM, Kang WK.

J Clin Oncol. 2012 Jan 20;30(3):268-73. doi: 10.1200/JCO.2011.39.1953. Epub 2011 Dec 19.

4.

An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

Kim S, Lim DH, Lee J, Kang WK, MacDonald JS, Park CH, Park SH, Lee SH, Kim K, Park JO, Kim WS, Jung CW, Park YS, Im YH, Sohn TS, Noh JH, Heo JS, Kim YI, Park CK, Park K.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1279-85. Epub 2005 Aug 15.

PMID:
16099596
5.

Phase 3 trial of postoperative chemotherapy alone versus chemoradiation therapy in stage III-IV gastric cancer treated with R0 gastrectomy and D2 lymph node dissection.

Kim TH, Park SR, Ryu KW, Kim YW, Bae JM, Lee JH, Choi IJ, Kim YJ, Kim DY.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):e585-92. doi: 10.1016/j.ijrobp.2012.07.2378. Epub 2012 Sep 11.

PMID:
22975616
6.

Comparison of two different adjuvant treatment modalities for pN3 gastric cancer patients after D2 lymph node dissection: can we avoid radiotherapy in a subgroup of patients?

Kilic L, Ordu C, Ekenel M, Yildiz I, Keskin S, Sen F, Gural Z, Asoglu O, Kizir A, Aykan F.

Med Oncol. 2013;30(3):660. doi: 10.1007/s12032-013-0660-2. Epub 2013 Jul 23.

PMID:
23877872
7.

Adjuvant IMRT/XELOX radiochemotherapy improves long-term overall- and disease-free survival in advanced gastric cancer.

Boda-Heggemann J, Weiss C, Schneider V, Hofheinz RD, Haneder S, Michaely H, Wertz H, Ronellenfitsch U, Hochhaus A, Wenz F, Lohr F.

Strahlenther Onkol. 2013 May;189(5):417-23. doi: 10.1007/s00066-013-0309-2. Epub 2013 Apr 6.

PMID:
23558673
8.

Postoperative chemoradiotherapy for gastric cancer.

Park SH, Kim DY, Heo JS, Lim DH, Park CK, Lee KW, Choi SH, Sohn TS, Kim S, Noh JH, Kim YI, Park JO, Kim K, Kim WS, Jung CW, Im YH, Lee MH, Park K, Park CH, Kang WK.

Ann Oncol. 2003 Sep;14(9):1373-7.

9.

Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.

Leong CN, Chung HT, Lee KM, Shakespeare TP, Mukherjee RK, Wong LC, Lu JJ, Tey J, Lim R, So JB, Back MF.

Cancer J. 2008 Jul-Aug;14(4):269-75. doi: 10.1097/PPO.0b013e318178d23a.

PMID:
18677137
10.

Postoperative chemotherapy followed by conformal concomitant chemoradiotherapy in high-risk gastric cancer.

Quero L, Bouchbika Z, Kouto H, Baruch-Hennequin V, Gornet JM, Munoz N, Cojean-Zelek I, Houdart R, Panis Y, Valleur P, Aparicio T, Maylin C, Hennequin C.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):574-80. doi: 10.1016/j.ijrobp.2011.07.031. Epub 2011 Nov 16.

PMID:
22099038
11.

Combined adjuvant radiochemotherapy with IMRT/XELOX improves outcome with low renal toxicity in gastric cancer.

Boda-Heggemann J, Hofheinz RD, Weiss C, Mennemeyer P, Mai SK, Hermes P, Wertz H, Post S, Massner B, Hieber U, Hochhaus A, Wenz F, Lohr F.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1187-95. doi: 10.1016/j.ijrobp.2008.12.036. Epub 2009 May 4.

PMID:
19409725
12.

Image-guided intensity-modulated radiotherapy for patients with locally advanced gastric cancer: a clinical feasibility study.

Badakhshi H, Gruen A, Graf R, Boehmer D, Budach V.

Gastric Cancer. 2014;17(3):537-41. doi: 10.1007/s10120-013-0310-6. Epub 2013 Oct 11.

PMID:
24122094
13.

Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer.

Dikken JL, Jansen EP, Cats A, Bakker B, Hartgrink HH, Kranenbarg EM, Boot H, Putter H, Peeters KC, van de Velde CJ, Verheij M.

J Clin Oncol. 2010 May 10;28(14):2430-6. doi: 10.1200/JCO.2009.26.9654. Epub 2010 Apr 5.

14.
15.

Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.

Chakravarty T, Crane CH, Ajani JA, Mansfield PF, Briere TM, Beddar AS, Mok H, Reed VK, Krishnan S, Delclos ME, Das P.

Int J Radiat Oncol Biol Phys. 2012 Jun 1;83(2):581-6. doi: 10.1016/j.ijrobp.2011.07.035. Epub 2011 Dec 2.

PMID:
22137021
16.

Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery.

Yu C, Yu R, Zhu W, Song Y, Li T.

J Cancer Res Clin Oncol. 2012 Feb;138(2):255-9. doi: 10.1007/s00432-011-1085-y. Epub 2011 Nov 22.

PMID:
22105898
17.

Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.

Folkert MR, Shih KK, Abu-Rustum NR, Jewell E, Kollmeier MA, Makker V, Barakat RR, Alektiar KM.

Gynecol Oncol. 2013 Feb;128(2):288-93. doi: 10.1016/j.ygyno.2012.11.012. Epub 2012 Nov 15.

PMID:
23159818
18.

Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.

Fu S, Lu JJ, Zhang Q, Yang Z, Peng L, Xiong F.

Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1488-94. doi: 10.1016/j.ijrobp.2008.03.012. Epub 2008 Jun 4.

PMID:
18538489
19.

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, Messerini L, Arcangeli A, Torri V, Bilancia D, Floriani I, Tonato M; Italian Oncology Group for Cancer Research, Dinota A, Strafiuso G, Corgna E, Porrozzi S, Boni C, Rondini E, Giunta A, Monzio Compagnoni B, Biagioni F, Cesari M, Fornarini G, Nelli F, Carboni M, Cognetti F, Enzo MR, Piga A, Romiti A, Olivetti A, Masoni L, De Stefanis M, Dalla Mola A, Camera S, Recchia F, De Filippis S, Scipioni L, Zironi S, Luppi G, Italia M, Banducci S, Pisani Leretti A, Massidda B, Ionta MT, Nicolosi A, Canaletti R, Biscottini B, Grigniani F, Di Costanzo F, Rovei R, Croce E, Carroccio R, Gilli G, Cavalli C, Olgiati A, Pandolfi U, Rossetti R, Natalini G, Foa P, Oldani S, Bruno L, Cascinu S, Catalano G, Catalano V, Lungarotti F, Farris A, Sarobba MG, Trignano M, Muscogiuri A, Francavilla F, Figoli F, Leoni M, Papiani G, Orselli G, Antimi M, Bellini V, Cabassi A, Contu A, Pazzola A, Frignano M, Lastraioli E, Saggese M, Bianchini D, Antonuzzo L, Mela M, Camisa R.

J Natl Cancer Inst. 2008 Mar 19;100(6):388-98. doi: 10.1093/jnci/djn054. Epub 2008 Mar 11.

20.

Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.

Minn AY, Hsu A, La T, Kunz P, Fisher GA, Ford JM, Norton JA, Visser B, Goodman KA, Koong AC, Chang DT.

Cancer. 2010 Aug 15;116(16):3943-52. doi: 10.1002/cncr.25246.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk